View Document Preview and Link
Document Date: 2014-06-23 22:20:38 Open Document File Size: 1,26 MB Share Result on Facebook
Company Astra Zeneca / Eli Lilly / Sanofi Aventis / Expected Return Capital / Makhteshim Agan / Phase III BV / Symptomatic Relief VivaGel BV / VivaGel VivaGel VivaGel Dendrimer-Docetaxel Dendrimer-Glyphosate BV / Gowan Company / Nufarm / GlaxoSmithKline / Ansell Dendrimer-Docetaxel (first solid tumour) Dendrimer-Glyphosate Diagnostics / Elanco / GSK / Risk Speculative GICS Sector Pharmaceuticals / VivaGel BV / Okamoto Industries / / Country Japan / United States / / Currency AUD / USD / / Event Business Partnership / FDA Phase / / Facility Laboratory Reagents Other Pipeline / In laboratory / Terminal Growth / Terminal Growth Rate At / / IndustryTerm promising technology / platform technology / pharmaceutical / pharmaceutical platform technology / manufacturing / chemical / / MarketIndex S&P 300 / / MedicalCondition Viral Conjunctivitis / gastric cancer / HIV / genital herpes / Bacterial Vaginosis / head and neck cancer / prostate cancer / breast cancer / NSCLC / HPV / infection / tumours / / MedicalTreatment oral contraceptives / dendrimer / contraception / drainage / dendrimers / / Organization NM PER / United Nations Population Fund / FDA / / Person BELL POTTER / Seiji Takeuchi / Tanushree Jain / / Position MODEL AT THIS STAGE / MANAGER IN THE OCTOBER / LEAD MANAGER / player / leader / managing director / forward / Speculative Analyst / / Product Taxotere / CY2H15 / VivaGel / FY15 / / Technology promising technology / drug-delivery / Biotechnology / drug delivery / platform technology / / SocialTag